SLC22A17 and esophageal cancer: In particular, it has been reported that both SLC22A17 isoforms 1 and 2 are bilateral iron transporters, while SLC22A17 isoform 3 could exclusively mediate iron influx in esophageal cancer cells (Candido et al., 2014; Xiao et al., 2017).